TAOX Tao Synergies Inc. - Common Stock
$3.13
Price · Aug 19, 2026
Fundamentals as of Aug 13, 2026
52W Range
$3–$10
0% of range
Analyst Rating
BUY
7 analysts
Price Target
—
P/E (TTM)
-0.4
ROE
-150.1%
Net Profit Margin
-9609.2%
TAOX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.13
Market Cap
$23M
P/E (TTM)
-0.4
EPS (TTM)
$-8.81
Revenue (TTM)
$299.1K
Div Yield
—
ROE
-150.1%
Debt/Equity
—
52W Range
$3 – $10
TAOX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$299.1K
2024-12-31
→
2025-12-31
EPS
$-8.81
2020-12-31
→
2025-12-31
Free Cash Flow
—
2020-12-31
→
2023-12-31
Margins
-9609.2%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
TAOX
Peer Median
P/E (TTM)
-0.4
132.0
P/S (TTM)
78.0
4.9
P/B
1.1
5.1
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
TAOX
Peer Median
Operating Margin
-3025.2%
—
Net Profit Margin
-9609.2%
-35.8%
ROA
-131.9%
-20.8%
ROE
-150.1%
-29.7%
ROIC
-43.0%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
TAOX
Peer Median
Current Ratio
14.0
3.6
Quick Ratio
3.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
TAOX
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
TAOX
Peer Median
TAOX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
1.4%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2024 | $-2.25 | $-2.10 | -0.15% |
| Sept. 30, 2024 | $-4.58 | $-1.99 | -2.6% |
| June 30, 2024 | $-1.18 | $-1.87 | 0.69% |
| March 31, 2023 | $-6.50 | $-14.28 | 7.8% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| TAOX | $27M | -0.4 | — | -9609.2% | -150.1% | — |
| AWRE | — | -6.6 | -0.55% | — | — | — |
| DFNS | $77M | 0.5 | -72.2% | — | -214.7% | — |
| NTRP | $40M | -1.6 | 641.0% | -428.2% | -290.2% | 17.6% |
| AMOD | — | — | — | — | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $299.1K | $0 | |
| Cost of Revenue | $38.3K | $0 | |
| R&D Expense | $322.2K | $2M | |
| SG&A Expense | $9M | $5M | |
| Operating Expenses | $9M | $7M | |
| Operating Income | $-9M | $-7M | |
| Other Non-op | $-20M | $-6M | |
| Pretax Income | $-29M | $-13M | |
| Income Tax | $0 | $0 | |
| Net Income | $-29M | $-13M | |
| EPS (Basic) | $-8.81 | $-10.99 | |
| EPS (Diluted) | $-8.81 | $-10.99 | |
| Shares (Basic) | 3,300,200 | 1,233,700 | |
| Shares (Diluted) | 3,300,200 | 1,233,700 | |
| EBITDA | $-9M | $5.6K |
Balance Sheet 16
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $5M | $18M | |
| Prepaid Expense | $2M | $64.6K | |
| Current Assets | $25M | $18M | |
| PP&E (Net) | $9.3K | $12.9K | |
| Total Assets | $26M | $18M | |
| Accounts Payable | $1M | $317.3K | |
| Accrued Liabilities | $638.5K | $697.0K | |
| Current Liabilities | $2M | $1M | |
| Total Liabilities | $4M | $11M | |
| Common Stock | $746 | $137 | |
| Paid-in Capital | $97M | $53M | |
| Retained Earnings | $-76M | $-47M | |
| AOCI | $5.7K | $5.7K | |
| Stockholders' Equity | $21M | $6M | |
| Liabilities + Equity | $26M | $18M | |
| Shares Outstanding | 7,448,343 | 1,357,165 |
Cash Flow 5
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $3.6K | $5.6K | |
| Other Non-cash | $22M | $8M | |
| Operating Cash Flow | $-6M | $-5M | |
| Investing Cash Flow | $-29M | $-1M | |
| Financing Cash Flow | $23M | $-5M |
Profitability 7
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -3025.2% | · | |
| Net Margin | -9609.2% | · | |
| Pretax Margin | -9609.2% | · | |
| EBITDA Margin | -3024.0% | · | |
| ROA | -131.9% | -52.3% | |
| ROE | -150.1% | -136.8% | |
| ROIC | -43.0% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 14.0 | 17.5 | |
| Quick Ratio | 3.0 | 17.4 |
Efficiency 1
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · |
Valuation (TTM) 9
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $299.1K | $0 | |
| Net Income TTM | $-29M | $-13M | |
| Market Cap | $27M | $5M | |
| P/E | -0.4 | -0.3 | |
| P/S | 91.7 | · | |
| P/B | 1.3 | 0.8 | |
| P / Tangible Book | 1.3 | 0.8 | |
| P / Cash Flow | -4.3 | -1.0 | |
| Earnings Yield | -239.4% | -316.7% |
Income Statement 15
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Revenue | $88.6K | $388.8K | $91.7K | $203.4K | $4.0K | |
| Cost of Revenue | $22.1K | $17.4K | · | · | · | |
| R&D Expense | $31.9K | $28.6K | $58.5K | $54.4K | $148.6K | |
| SG&A Expense | $2M | $2M | $4M | $2M | $2M | |
| Operating Expenses | $2M | $2M | $3M | $2M | $3M | |
| Operating Income | $-2M | $-1M | $-3M | $-2M | $-3M | |
| Other Non-op | $-8M | $6M | $-5M | $-2M | $-14M | |
| Pretax Income | $-9M | $4M | $-8M | $-4M | $-18M | |
| Income Tax | $0 | $0 | · | · | $0 | |
| Net Income | $-9M | $4M | $-8M | $-4M | $-18M | |
| EPS (Basic) | $-1.83 | $0.45 | $3.89 | $-1.56 | $-11.26 | |
| EPS (Diluted) | $-1.83 | $0.43 | $3.97 | $-1.56 | $-11.26 | |
| Shares (Basic) | 7,472,200 | 7,481,700 | -2,200,300 | 2,549,600 | 1,565,200 | |
| Shares (Diluted) | 7,472,200 | 7,699,102 | -2,207,481 | 2,549,600 | 1,565,200 | |
| EBITDA | $-2M | $-1M | · | $-2M | $-3M |
Balance Sheet 16
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $4M | $5M | · | $14M | |
| Prepaid Expense | $1M | $1M | $2M | $2M | $921.3K | |
| Current Assets | $21M | $30M | $25M | $18M | $20M | |
| PP&E (Net) | $7.8K | $8.5K | $9.3K | $10.1K | $10.9K | |
| Total Assets | $21M | $31M | $26M | $18M | $20M | |
| Accounts Payable | $899.2K | $946.3K | $1M | $949.6K | $898.2K | |
| Accrued Liabilities | $132.4K | $157.4K | $638.5K | $92.4K | $66.1K | |
| Current Liabilities | $1M | $1M | $2M | $1M | $964.3K | |
| Total Liabilities | $4M | $5M | $4M | $2M | $2M | |
| Common Stock | $748 | $748 | $746 | $453 | $251 | |
| Paid-in Capital | $94M | $95M | $97M | $85M | $82M | |
| Retained Earnings | $-82M | $-72M | $-76M | $-68M | $-65M | |
| AOCI | $5.7K | $5.7K | $5.7K | $5.7K | $5.7K | |
| Stockholders' Equity | $13M | $23M | $21M | $16M | $17M | |
| Liabilities + Equity | $21M | $31M | $26M | $18M | $20M | |
| Shares Outstanding | 7,473,112 | 7,471,931 | 7,448,343 | 4,527,412 | 2,504,911 |
Cash Flow 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| D&A | $735 | $816 | $802 | $803 | $979 | |
| Other Non-cash | · | $-6M | · | · | · | |
| Operating Cash Flow | $-875.0K | $-2M | $-2M | $-1M | $-749.1K | |
| Investing Cash Flow | · | · | $-11M | $-13M | · | |
| Financing Cash Flow | $-402.4K | $-169.0K | $18M | $1M | $5M |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Operating Margin | -1770.6% | -338.9% | · | -884.8% | -76623.8% | |
| Net Margin | -10492.4% | 1094.3% | · | -1929.1% | -442101.9% | |
| Pretax Margin | -10492.4% | 1094.3% | · | -1929.1% | -442101.9% | |
| EBITDA Margin | -1770.6% | -338.7% | · | -884.8% | -76623.8% | |
| ROA | -45.5% | 18.4% | · | -19.1% | -72.7% | |
| ROE | -62.0% | 29.9% | · | -27.2% | -97.2% | |
| ROIC | -12.3% | -5.7% | · | · | · |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 20.0 | 27.4 | · | 17.6 | 20.5 | |
| Quick Ratio | 2.3 | 3.3 | · | · | 14.9 |
Efficiency 1
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 |
Valuation (TTM) 9
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Revenue TTM | $684.7K | · | · | · | · | |
| Net Income TTM | $-26M | $-17M | · | $-27M | $-24M | |
| Market Cap | $28M | $43M | · | $30M | $20M | |
| P/E | -0.3 | -0.5 | · | -0.4 | -0.5 | |
| P/S | 40.7 | · | · | · | · | |
| P/B | 2.2 | 1.8 | · | 1.8 | 1.1 | |
| P / Tangible Book | 2.2 | 1.8 | · | 1.8 | 1.1 | |
| P / Cash Flow | · | -25.3 | · | · | · | |
| Earnings Yield | -381.2% | -217.1% | · | -271.6% | -221.8% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $299.1K | $0 | — | — | — |
| Operating Margin % | -3025.2% | — | — | — | — |
| Net Income | $-29M | $-13M | $-6M | $-6M | $-13M |
| Diluted EPS | $-8.81 | $-10.99 | $29.56 | $-0.81 | $2.51 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 14.0 | 17.5 | 7.1 | 29.4 | 17.8 |
| Quick Ratio | 3.0 | 17.4 | 6.7 | 28.5 | 17.2 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | — | — | $-5M | $-11M | $-9M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 30 filers · $2.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 8 (0 vs prior Q) | 2 (-6 vs prior Q) | 7 (+1 vs prior Q) | 4 (+1 vs prior Q) | +102K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $441,897 | 118,471 | 21.93% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $293,987 | 78,817 | 14.59% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $247,256 | 66,235 | 12.27% | Shares |
| Summit Financial, LLC | $215,445 | 57,760 | 10.69% | Shares |
| JANE STREET GROUP, LLC | $138,103 | 37,025 | 6.85% | Shares |
| UBS Group AG | $122,266 | 32,779 | 6.07% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $118,946 | 31,889 | 5.90% | Shares |
| VANGUARD GROUP INC | $95,426 | 25,931 | 4.74% | Shares |
| STATE STREET CORP | $93,996 | 25,200 | 4.67% | Shares |
| MORGAN STANLEY | $90,859 | 24,359 | 4.51% | Shares |
| NORTHERN TRUST CORP | $51,933 | 13,923 | 2.58% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $47,069 | 12,619 | 2.34% | Shares |
| Blue Trust, Inc. | $10,563 | 2,832 | 0.52% | Shares |
| Steward Partners Investment Advisory, LLC | $10,444 | 2,800 | 0.52% | Shares |
| MassMutual Private Wealth & Trust, FSB | $10,071 | 2,700 | 0.50% | Shares |
| Tower Research Capital LLC (TRC) | $9,000 | 2,413 | 0.45% | Shares |
| BlackRock, Inc. | $6,035 | 1,618 | 0.30% | Shares |
| PNC Financial Services Group, Inc. | $2,798 | 750 | 0.14% | Shares |
| CITADEL ADVISORS LLC | $2,663 | 714 | 0.13% | Shares |
| SBI Securities Co., Ltd. | $1,940 | 520 | 0.10% | Shares |
| Colonial Trust Advisors | $1,865 | 500 | 0.09% | Shares |
| OSAIC HOLDINGS, INC. | $820 | 220 | 0.04% | Shares |
| BARCLAYS PLC | $436 | 117 | 0.02% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $251 | 70 | 0.01% | Shares |
| Federation des caisses Desjardins du Quebec | $187 | 50 | 0.01% | Shares |
| HRT FINANCIAL LP | $149 | 40,072 | 0.01% | Shares |
| Allworth Financial LP | $112 | 30 | 0.01% | Shares |
| Lodestone Wealth Management LLC | $75 | 20 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $48 | 13 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 8 | 0.00% | Shares |
Company insiders 9 insiders · 4 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Robert Weinstein | Chief Financial Officer | May 18, 2026 A | 16,574 | 0 | 0 | $0 |
| Daniel L. Alkon | President and CSO | Dec. 16, 2022 S | 35,546 | 0 | 0 | $0 |
| Joshua Silverman | Executive Chairman | May 18, 2026 A | 86,681 | 0 | 0 | $0 |
| Alan J Tuchman | Chief Medical Officer | June 30, 2025 F | 3,909 | 0 | 0 | $0 |
| Robert Ephron | Director | May 18, 2026 A | 4,500 | 0 | 0 | $0 |
| Bruce Bernstein | Director | May 18, 2026 A | 30,897 | 0 | 0 | $0 |
| William S. Singer | Director | May 18, 2026 A | 19,566 | 0 | 0 | $0 |
| Jonathan Schechter | Director | Aug. 6, 2025 A | 14,035 | 0 | 0 | $0 |
| George Perry | Director | July 13, 2021 A | 40,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.